ID   ACT-1 [Human adrenocortical carcinoma]
AC   CVCL_6290
DR   Wikidata; Q54608557
RX   PubMed=11168692;
RX   PubMed=21924324;
CC   Population: Japanese.
CC   Doubling time: 24 hours (Note=At 26th passage) (PubMed=11168692).
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
DI   NCIt; C9325; Adrenal cortex carcinoma
DI   ORDO; Orphanet_1501; Adrenocortical carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
RX   PubMed=21924324; DOI=10.1016/j.mce.2011.08.041; PMCID=PMC3288152;
RA   Wang, Tao
RA   Rainey, William E.
RT   "Human adrenocortical carcinoma cell lines.";
RL   Mol. Cell. Endocrinol. 351:58-65(2012).
//
RX   PubMed=11168692; DOI=10.1046/j.1442-2042.2001.00238.x;
RA   Ueno, Munehisa
RA   Nakashima, Jun
RA   Akita, Masumi
RA   Ban, Shin-ichi
RA   Nakanoma, Takashi
RA   Iida, Masahiro
RA   Deguchi, Nobuhiro
RT   "Characterization of a newly established cell line derived from human
RT   adrenocortical carcinoma.";
RL   Int. J. Urol. 8:17-22(2001).
//